2021 CSCO 肾癌诊疗指南

2021-08-01 中国临床肿瘤学会指南工作委员会 人民卫生出版社

肾癌是中国三大常见泌尿系统肿瘤之一,在我国发病率呈现逐年上升趋势。2021年8月,中国临床肿瘤学会指南工作委员会发布《肾癌诊疗指南2021》。

中文标题:

2021 CSCO 肾癌诊疗指南

发布日期:

2021-08-01

简要介绍:

肾癌是中国三大常见泌尿系统肿瘤之一,在我国发病率呈现逐年上升趋势。数据显示,2020 年度全球肾癌发病人数为 43.1 万,死亡人数为 17.9 万;我国的发病人数为 7.3 万,死亡人数为 4.3 万。肾癌的治疗在外科及内科方面均取得了快速发展,相关治疗引领了泌尿肿瘤治疗方向的前进。2021年8月,中国临床肿瘤学会指南工作委员会发布《肾癌诊疗指南2021》。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021CSCO肾癌诊疗指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=42ac51c002293082, title=2021 CSCO 肾癌诊疗指南, enTitle=, guiderFrom=人民卫生出版社, authorId=0, author=, summary=肾癌是中国三大常见泌尿系统肿瘤之一,在我国发病率呈现逐年上升趋势。2021年8月,中国临床肿瘤学会指南工作委员会发布《肾癌诊疗指南2021》。, cover=https://img.medsci.cn/20211216/1639668205032_5579292.png, journalId=0, articlesId=null, associationId=1983, associationName=中国临床肿瘤学会指南工作委员会, associationIntro=中国临床肿瘤学会指南工作委员会, copyright=0, guiderPublishedTime=Sun Aug 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>肾癌是中国三大常见泌尿系统肿瘤之一,在我国发病率呈现逐年上升趋势。数据显示,2020 年度全球肾癌发病人数为 43.1 万,死亡人数为 17.9 万;我国的发病人数为 7.3 万,死亡人数为 4.3 万。肾癌的治疗在外科及内科方面均取得了快速发展,相关治疗引领了泌尿肿瘤治疗方向的前进。2021年8月,中国临床肿瘤学会指南工作委员会发布《肾癌诊疗指南2021》。</p>, tagList=[TagDto(tagId=330, tagName=肾癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=330, guiderKeyword=肾癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=113440, appHits=341, showAppHits=0, pcHits=3002, showPcHits=113097, likes=1, shares=31, comments=19, approvalStatus=1, publishedTime=Thu Dec 16 23:11:35 CST 2021, publishedTimeString=2021-08-01, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Dec 16 23:28:04 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 00:02:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021CSCO肾癌诊疗指南.pdf)])
2021CSCO肾癌诊疗指南.pdf
下载请点击:
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2123189, encodeId=645421231896b, content=肾癌, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbd94309733, createdName=13f54c01m88暂无昵称, createdTime=Sat Apr 01 21:42:29 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214272, encodeId=069a12142e2c9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82594, encryptionId=8f5c82594d5, topicName=肾癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:25:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209763, encodeId=0d151209e6381, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/fc195ae5117746e7809f4a726028a18f/704a1f9f75af4976b7580b7aad5aad62.jpg, createdBy=5b1f2905386, createdName=米七, createdTime=Sat Apr 09 10:37:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190116, encodeId=a8a5119011620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80945645978, createdName=ms6000000988275140, createdTime=Fri Feb 04 11:48:13 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185353, encodeId=dadb118535357, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Mon Jan 17 22:20:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2023-04-01 13f54c01m88暂无昵称 来自山东省

    肾癌

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2123189, encodeId=645421231896b, content=肾癌, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbd94309733, createdName=13f54c01m88暂无昵称, createdTime=Sat Apr 01 21:42:29 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214272, encodeId=069a12142e2c9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82594, encryptionId=8f5c82594d5, topicName=肾癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:25:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209763, encodeId=0d151209e6381, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/fc195ae5117746e7809f4a726028a18f/704a1f9f75af4976b7580b7aad5aad62.jpg, createdBy=5b1f2905386, createdName=米七, createdTime=Sat Apr 09 10:37:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190116, encodeId=a8a5119011620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80945645978, createdName=ms6000000988275140, createdTime=Fri Feb 04 11:48:13 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185353, encodeId=dadb118535357, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Mon Jan 17 22:20:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2123189, encodeId=645421231896b, content=肾癌, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbd94309733, createdName=13f54c01m88暂无昵称, createdTime=Sat Apr 01 21:42:29 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214272, encodeId=069a12142e2c9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82594, encryptionId=8f5c82594d5, topicName=肾癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:25:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209763, encodeId=0d151209e6381, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/fc195ae5117746e7809f4a726028a18f/704a1f9f75af4976b7580b7aad5aad62.jpg, createdBy=5b1f2905386, createdName=米七, createdTime=Sat Apr 09 10:37:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190116, encodeId=a8a5119011620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80945645978, createdName=ms6000000988275140, createdTime=Fri Feb 04 11:48:13 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185353, encodeId=dadb118535357, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Mon Jan 17 22:20:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-04-09 米七

    值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2123189, encodeId=645421231896b, content=肾癌, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbd94309733, createdName=13f54c01m88暂无昵称, createdTime=Sat Apr 01 21:42:29 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214272, encodeId=069a12142e2c9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82594, encryptionId=8f5c82594d5, topicName=肾癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:25:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209763, encodeId=0d151209e6381, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/fc195ae5117746e7809f4a726028a18f/704a1f9f75af4976b7580b7aad5aad62.jpg, createdBy=5b1f2905386, createdName=米七, createdTime=Sat Apr 09 10:37:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190116, encodeId=a8a5119011620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80945645978, createdName=ms6000000988275140, createdTime=Fri Feb 04 11:48:13 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185353, encodeId=dadb118535357, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Mon Jan 17 22:20:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-04 ms6000000988275140

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2123189, encodeId=645421231896b, content=肾癌, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbd94309733, createdName=13f54c01m88暂无昵称, createdTime=Sat Apr 01 21:42:29 CST 2023, time=2023-04-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1214272, encodeId=069a12142e2c9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82594, encryptionId=8f5c82594d5, topicName=肾癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:25:39 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209763, encodeId=0d151209e6381, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/fc195ae5117746e7809f4a726028a18f/704a1f9f75af4976b7580b7aad5aad62.jpg, createdBy=5b1f2905386, createdName=米七, createdTime=Sat Apr 09 10:37:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190116, encodeId=a8a5119011620, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80945645978, createdName=ms6000000988275140, createdTime=Fri Feb 04 11:48:13 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185353, encodeId=dadb118535357, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Mon Jan 17 22:20:16 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-17 ms9000001252511009

    学习了

    0